Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.34 |
| ▸ | BACE1 | P56817 | 4/20 | 0.31 |
| ▸ | CTSD | P07339 | 3/20 | 0.31 |
| ▸ | CTSE | P14091 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31129064 | 0.80 | SLC7A5 (0.41) | SLC7A5BACE1CTSDCTSE | |
| SCHEMBL29697640 | 0.80 | SLC7A5 (0.33) | SLC7A5 | |
| SCHEMBL30534361 | 0.77 | SLC7A5 (0.38) | SLC7A5 | |
| SCHEMBL11459947 | 0.77 | SLC7A5 (0.52) | SLC7A5 | |
| SCHEMBL11459948 | 0.77 | SLC7A5 (0.52) | SLC7A5 | |
| SCHEMBL31634275 | 0.77 | ALDH1A1 (0.46) | SLC7A5 | |
| SCHEMBL30522092 | 0.76 | ALDH1A1 (0.35) | — | |
| SCHEMBL30277766 | 0.75 | CTSK (0.52) | BACE1 | |
| SCHEMBL30499068 | 0.74 | SLC7A5 (0.41) | SLC7A5 | |
| SCHEMBL23056665 | 0.74 | SLC7A5 (0.41) | SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12331072-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-17 | — | — | US | disclosed |
| US-20250188116-A1 | DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-06-12 | — | — | US | disclosed |
| CN-119143631-A | Deprotection method for peptide compound or amide compound and resin removal method in solid phase reaction and method for producing peptide compound | 中外制药株式会社 | 2024-12-17 | — | — | CN | disclosed |
| CN-113056475-B | Deprotection method for peptide compound or amide compound and resin removal method in solid phase reaction and method for producing peptide compound | 中外制药株式会社 | 2024-09-24 | — | — | CN | disclosed |
| US-20230303619-A1 | DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-09-28 | — | — | US | disclosed |
| US-11732002-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11732002-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | VIP, PEPD, MLN | SLC7A5 1760/4885BACE1 1865/4885CTSD 237/4885 |
| US-12331072-B2 | Deprotection method and resin removal method in solid-phase reaction for peptide compound or amide compound, and method for producing peptide compound | VIP, PEPD, MLN | SLC7A5 1760/4885BACE1 1865/4885CTSD 237/4885 |
| US-20230303619-A1 | DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND | VIP, PEPD, MLN | SLC7A5 1760/4885BACE1 1865/4885CTSD 237/4885 |
| US-20250188116-A1 | DEPROTECTION METHOD AND RESIN REMOVAL METHOD IN SOLID-PHASE REACTION FOR PEPTIDE COMPOUND OR AMIDE COMPOUND, AND METHOD FOR PRODUCING PEPTIDE COMPOUND | VIP, PEPD, MLN | SLC7A5 1760/4885BACE1 1865/4885CTSD 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.